Cancer Gateway

Welcome to BioMed Central's Cancer Gateway, highlighting the latest articles we have published in this field. Content is continually updated, so please bookmark this page and ensure you check it regularly.


There has been an error retrieving the data. Please try again.
  • Computer-aided discovery of new breast cancer therapeutics

    A combination of virtual screening and biochemical assays identified new small-molecule estrogen receptor inhibitors with the potential for use in novel endocrine-based therapies.

    Breast Cancer Research 2015, 17:27
  • miRNAs in CLL onset and progression

    Carlo Croce and colleagues review the roles of a few key miRNAs in chronic lymphocytic leukemia (CLL) and the potential for identifying new biomarkers and treatment approaches.

    Journal of Hematology & Oncology 2015, 8:12
  • Image attributed to: From wikimedia, by Nilfanion and Dr Greg, CC

    Cancer risk by ethnicity in England

    Analysis of cancer incidence data in England reveals that risk of breast and gynaecological cancers varies by ethnic group but groups typically grouped together are not homogenous with regards to their cancer risk.

    BMC Cancer 2014, 14:979
  • Image attributed to: From Fig 2, Lim et al, BMC Cancer 2014, 14:928

    APP promotes breast cancer aggressiveness

    The overexpression in breast cancer cells of Amyloid-beta precursor protein (APP), involved in Alzheimer’s disease, is linked to tumorigenicity and invasion, and APP may serve as a target for breast cancer therapy.

    BMC Cancer 2014, 14:928
  • Functions of lncRNA HOTAIR in lung cancer

    Loewen et al. discuss how exploiting the role of long noncoding RNA HOTAIR in proliferation, survival, invasion, metastasis, and drug resistance in lung cancer cells could potentially diagnose and treat lung cancer.

    Journal of Hematology & Oncology 2014, 7:90


Authors of BioMed Central cancer-related articles, by location

Powered by

News and events

Biomarker Research, a new journal encompassing all aspects biomarker investigation, has now launched. Visit the journal website to read the first articles, including a review by co-Editor-in-Chief Delong Liu on the clinical applications of JAK inhibitors, and sign up for article alerts.


Author profile

Wei Zhang

Director, Cancer Genomics Core Lab, University of Texas